Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at -1.02% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
Flat results in Mar 26
Stock is technically in a Mildly Bearish range
Risky - Negative EBITDA
Stock DNA
Garments & Apparels
INR 38 Cr (Micro Cap)
NA (Loss Making)
32
0.00%
0.83
-26.36%
4.79
Total Returns (Price + Dividend) 
Skybiotech Healt for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Skybiotech Healthcare Limited is Rated Strong Sell
Skybiotech Healthcare Limited is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More Announcements 
Board Meeting Outcome for Submission Of Outcome Of Board Meeting And Submission Of Financial Results For The Quarter And Year Ended On 31St March 2026
30-May-2026 | Source : BSESubmission of Outcome of board meeting and Financial Results for the quarter and year ended on 31st March 2026
Results Financials For The Year Ended On 31St March 2026
30-May-2026 | Source : BSESubmission of Financial Results for the Quarter and Year ended on 31st March 2026
Board Meeting Intimation for Approval Of Audited Results For The Quarter And Year Ended On March 31 2026
26-May-2026 | Source : BSESkybiotech Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Approval of Audited Results for the Quarter and Year ended on March 31 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Prakashchandra Rathi (45.16%)
Ganesh Shivprasad Lahoti (4.44%)
34.65%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Mar 2026 is 105.00% vs -140.82% in Mar 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 100.00% vs 50.00% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -500.00% vs -100.95% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 0.71% vs 0.00% in Mar 2025
YoY Growth in year ended Mar 2026 is 52.74% vs -253.90% in Mar 2025